Immunology/Inflammation


The adaptive immune system consists of B and T lymphocytes which mediate humoral immunity (e.g. antibody response) and cell-mediated immunity, respectively. B cell receptor and T cell receptor signaling is responsible for activation of Src family tyrosine kinases, such as Blk, Fyn, and Lyn in B cells and Fyn and Lck in T cells, resulting phosphorylation of the receptor-associated ITAM motifs. Phosphorylated ITAMs serve as the docking sites for Syk family tyrosine kinases, e.g. Syk in B cells and Zap-70 in T cells. Activated Syk kinases then propagate the signals via phosphorylation of downstream proteins. Furthermore, lymphocyte receptor signaling facilitates B and T cell development, differentiation, proliferation and survival.
-
BA6140 CA-170Summary: CA-170 is an oral dual inhibitor. -
BA6145 LatikafuspSummary: Latikafusp (AMG256) is a bifunctional fusion protein containing targeted antibodies and mutant proteins designed to provide pathway stimulation to PD-1+ cells. -
BA6146 AcasunlimabSummary: Acasunlimab (GEN1046) is a bispecific antibody (bsAb) that targets and. -
BA6147 D18Summary: D18 is an immunomodulator. -
BA6149 TPP-1Summary: TPP-1 is a potent inhibitor of the interaction. -
BA6150 BMS-37Summary: BMS-37 is an immune checkpoint inhibitor. -
BA6151 TagitanlimabSummary: Tagitanlimab has the potential to study recurrent or metastatic nasopharyngeal carcinoma (NPC). -
BA6152 PD-1-IN-24Summary: Inhibitors with oral activity. -
BA6155 ReozalimabSummary: Reozalimab is a targeted bispecific antibody. -
BA6156 NSC622608Summary: NSC622608 is a T cell activation V structural domain Ig inhibitor ligand.

